GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » ROA %

Sirnaomics (HKSE:02257) ROA % : -148.85% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sirnaomics's annualized Net Income for the quarter that ended in Jun. 2024 was HK$-641.44 Mil. Sirnaomics's average Total Assets over the quarter that ended in Jun. 2024 was HK$430.92 Mil. Therefore, Sirnaomics's annualized ROA % for the quarter that ended in Jun. 2024 was -148.85%.

The historical rank and industry rank for Sirnaomics's ROA % or its related term are showing as below:

HKSE:02257' s ROA % Range Over the Past 10 Years
Min: -121.7   Med: -65.79   Max: -43.6
Current: -104.62

During the past 5 years, Sirnaomics's highest ROA % was -43.60%. The lowest was -121.70%. And the median was -65.79%.

HKSE:02257's ROA % is ranked worse than
83.67% of 1500 companies
in the Biotechnology industry
Industry Median: -34.715 vs HKSE:02257: -104.62

Sirnaomics ROA % Historical Data

The historical data trend for Sirnaomics's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics ROA % Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
-65.99 -64.76 -121.70 -43.60 -65.79

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROA % Get a 7-Day Free Trial Premium Member Only -37.23 -49.33 -52.95 -81.47 -148.85

Competitive Comparison of Sirnaomics's ROA %

For the Biotechnology subindustry, Sirnaomics's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirnaomics's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirnaomics's ROA % distribution charts can be found below:

* The bar in red indicates where Sirnaomics's ROA % falls into.


';

Sirnaomics ROA % Calculation

Sirnaomics's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-614.561/( (1276.268+591.881)/ 2 )
=-614.561/934.0745
=-65.79 %

Sirnaomics's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-641.436/( (591.881+269.968)/ 2 )
=-641.436/430.9245
=-148.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Sirnaomics  (HKSE:02257) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-641.436/430.9245
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-641.436 / 0)*(0 / 430.9245)
=Net Margin %*Asset Turnover
=N/A %*0
=-148.85 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Sirnaomics ROA % Related Terms

Thank you for viewing the detailed overview of Sirnaomics's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirnaomics Business Description

Traded in Other Exchanges
N/A
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines